采用心脏收缩力调节疗法治疗的遗传性心肌病和严重收缩性心力衰竭。 - Suppr

Suppr

超能文献

Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy.

作者信息

Hesselson Aaron B, Vaidya Gaurang, Kolodziej Andrew

机构信息

Gill Heart and Vascular Institute, University of Kentucky, Lexington, Kentucky.

出版信息

Heart Rhythm O2. 2024 Jun 20;5(8):592-596. doi: 10.1016/j.hroo.2024.06.008. eCollection 2024 Aug.

DOI:10.1016/j.hroo.2024.06.008

PMID:39263608

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11385398/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4c0/11385398/e04b6693362e/gr1.jpg

相似文献

Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy.采用心脏收缩力调节疗法治疗的遗传性心肌病和严重收缩性心力衰竭。

Heart Rhythm O2. 2024 Jun 20;5(8):592-596. doi: 10.1016/j.hroo.2024.06.008. eCollection 2024 Aug.

Cardiac Overexpression of XIN Prevents Dilated Cardiomyopathy Caused by ΔK210 Mutation.XIN在心脏中的过表达可预防由ΔK210突变引起的扩张型心肌病。

Front Cell Dev Biol. 2021 Jun 17;9:691749. doi: 10.3389/fcell.2021.691749. eCollection 2021.

Rare and potential pathogenic mutations of LMNA and LAMA4 associated with familial arrhythmogenic right ventricular cardiomyopathy/dysplasia with right ventricular heart failure, cerebral thromboembolism and hereditary electrocardiogram abnormality.罕见且可能致病的 LMNA 和 LAMA4 突变与家族性心律失常性右室心肌病/发育不良伴右心衰竭、脑血栓栓塞和遗传性心电图异常相关。

Orphanet J Rare Dis. 2022 May 7;17(1):183. doi: 10.1186/s13023-022-02348-z.

All-Cause Mortality Outcomes of Usage of Cardiac Contractility Modulation in Patients With Dilated Cardiomyopathy Ineligible for Cardiac Re-Synchronization Therapy: An Updated Meta-Analysis of Randomized Controlled Trials.心脏再同步治疗不适用的扩张型心肌病患者使用心脏收缩力调制的全因死亡率结局：随机对照试验的更新荟萃分析

Cureus. 2020 Sep 24;12(9):e10627. doi: 10.7759/cureus.10627.

Normalization of ventricular function after cardiac contractility modulation in noncompaction cardiomyopathy heterozygous positive for a pathologic TTN gene variant.病理性TTN基因变异杂合阳性的非致密型心肌病患者经心脏收缩力调制后心室功能的正常化。

HeartRhythm Case Rep. 2022 Mar 29;8(6):449-452. doi: 10.1016/j.hrcr.2022.03.016. eCollection 2022 Jun.

Evaluation of 15 candidate genes for dilated cardiomyopathy in the Newfoundland dog.对纽芬兰犬扩张型心肌病的15个候选基因的评估。

J Hered. 2008 Jan-Feb;99(1):73-80. doi: 10.1093/jhered/esm090. Epub 2007 Nov 12.

Novel Genetic Variants in BAG3 and TNNT2 in a Swedish Family with a History of Dilated Cardiomyopathy and Sudden Cardiac Death.一个有扩张型心肌病和心源性猝死病史的瑞典家族中BAG3和TNNT2基因的新型变异

Pediatr Cardiol. 2017 Aug;38(6):1262-1268. doi: 10.1007/s00246-017-1655-0. Epub 2017 Jul 1.

Modulation of cytoskeleton in cardiomyopathy caused by mutations in gene.基因突变导致的心肌病中线粒体的调控。

Am J Physiol Cell Physiol. 2023 Jun 1;324(6):C1223-C1235. doi: 10.1152/ajpcell.00471.2022. Epub 2023 May 1.

Use of cardiac contractility modulation combined with left bundle branch pacing CRT-P in a female with a 22-year history of non-ischemic dilated cardiomyopathy: A case report.使用心肌收缩力调节联合左束支区域起搏治疗非缺血性扩张型心肌病 22 年的女性：病例报告。

Echocardiography. 2024 Mar;41(3):e15762. doi: 10.1111/echo.15762.

Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.扩张型心肌病的基因型-表型关联：对8000多名个体的荟萃分析

Clin Res Cardiol. 2017 Feb;106(2):127-139. doi: 10.1007/s00392-016-1033-6. Epub 2016 Aug 30.

本文引用的文献

First human implant of the cardiac contractility modulation in patient with dilated cardiomyopathy-related laminopathy.心脏收缩力调制在扩张型心肌病相关层粘连蛋白病患者中的首例人体植入。

HeartRhythm Case Rep. 2023 Mar 24;9(6):381-385. doi: 10.1016/j.hrcr.2023.03.011. eCollection 2023 Jun.

HeartRhythm Case Rep. 2022 Mar 29;8(6):449-452. doi: 10.1016/j.hrcr.2022.03.016. eCollection 2022 Jun.

Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study.缺血性与非缺血性心肌病患者的心肌收缩力调节：来自 MAINTAINED 观察性研究的结果。

Int J Cardiol. 2021 Nov 1;342:49-55. doi: 10.1016/j.ijcard.2021.07.048. Epub 2021 Jul 27.

Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond.心脏收缩力调节：在射血分数降低性心力衰竭中的作用机制及其他方面。

Eur J Heart Fail. 2019 Jan;21(1):14-22. doi: 10.1002/ejhf.1349. Epub 2018 Nov 28.

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.随机对照试验评估心脏收缩力调节的安全性和疗效。

JACC Heart Fail. 2018 Oct;6(10):874-883. doi: 10.1016/j.jchf.2018.04.010. Epub 2018 May 10.

MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy.MLP 和 CARP 与扩张型心肌病中的慢性 PKCα 信号传导有关。

Nat Commun. 2016 Jun 29;7:12120. doi: 10.1038/ncomms12120.

Posttranslational modifications of cardiac troponin T: an overview.心肌肌钙蛋白 T 的翻译后修饰：概述。

J Mol Cell Cardiol. 2013 Oct;63:47-56. doi: 10.1016/j.yjmcc.2013.07.004. Epub 2013 Jul 18.

Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure.心脏收缩力调制电信号可改善心力衰竭患者的心肌基因表达。

J Am Coll Cardiol. 2008 May 6;51(18):1784-9. doi: 10.1016/j.jacc.2008.01.036.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验